The biotechnology company produces medicines and treatments for allergic and inflammatory diseases, eye diseases, cancers, and more. Regeneron became a household name in 2020 when the U.S. government granted it a $450 million federal contract to develop an antibody drug to treat COVID-19. Former U.S. President Donald Trump reportedly received the treatment while hospitalized with the illness in October 2020.
Courtesy of Regeneron Pharmaceuticals.
Lists ranking Regeneron Pharmaceuticals
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...READ MOREview in list
100 Fastest-Growing Companies - 2020Collectively, the ranked companies produced a thre...READ MOREview in list
Latest news for Regeneron Pharmaceuticals
- HealthBiden administration moves to prevent shortage of COVID-19 antibody treatmentsSeptember 15, 2021 11:14 PM UTC
- HealthMeet the most innovative and inventive pharmaceutical companies of 2021April 16, 2021 10:00 AM UTC
- HealthCOVID treatments like the experimental antibody therapeutic Trump received are making progressOctober 7, 2020 10:15 PM UTC